title: International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation.
abstract: In 2005, the first guidelines were published on the management of patients with multiple myeloma (MM). An expert panel reviewed the currently available literature as the basis for a set of revised and updated consensus guidelines for the diagnosis and management of patients with MM who are not eligible for autologous stem cell transplantation. Here we present recommendations on the diagnosis, treatment of newly diagnosed non-transplant-eligible patients and the management of complications occurring during induction therapy among these patients. These guidelines will aid the physician in daily clinical practice and will ensure optimal care for patients with MM.
authors.affiliation: Divisione di Ematologia dell'Università di Torino, Azienda Ospedaliera S. Giovanni Battista, Ospedale Molinette, Torino 10126, Italy. appalumbo@yahoo.com
authors.forename: A
authors.initials: A
authors.lastname: Palumbo
authors.forename: O
authors.initials: O
authors.lastname: Sezer
authors.forename: R
authors.initials: R
authors.lastname: Kyle
authors.forename: J S
authors.initials: JS
authors.lastname: Miguel
authors.forename: R Z
authors.initials: RZ
authors.lastname: Orlowski
authors.forename: P
authors.initials: P
authors.lastname: Moreau
authors.forename: R
authors.initials: R
authors.lastname: Niesvizky
authors.forename: G
authors.initials: G
authors.lastname: Morgan
authors.forename: R
authors.initials: R
authors.lastname: Comenzo
authors.forename: P
authors.initials: P
authors.lastname: Sonneveld
authors.forename: S
authors.initials: S
authors.lastname: Kumar
authors.forename: R
authors.initials: R
authors.lastname: Hajek
authors.forename: S
authors.initials: S
authors.lastname: Giralt
authors.forename: S
authors.initials: S
authors.lastname: Bringhen
authors.forename: K C
authors.initials: KC
authors.lastname: Anderson
authors.forename: P G
authors.initials: PG
authors.lastname: Richardson
authors.forename: M
authors.initials: M
authors.lastname: Cavo
authors.forename: F
authors.initials: F
authors.lastname: Davies
authors.forename: J
authors.initials: J
authors.lastname: Bladé
authors.forename: H
authors.initials: H
authors.lastname: Einsele
authors.forename: M A
authors.initials: MA
authors.lastname: Dimopoulos
authors.forename: A
authors.initials: A
authors.lastname: Spencer
authors.forename: A
authors.initials: A
authors.lastname: Dispenzieri
authors.forename: T
authors.initials: T
authors.lastname: Reiman
authors.forename: K
authors.initials: K
authors.lastname: Shimizu
authors.forename: J H
authors.initials: JH
authors.lastname: Lee
authors.forename: M
authors.initials: M
authors.lastname: Attal
authors.forename: M
authors.initials: M
authors.lastname: Boccadoro
authors.forename: M
authors.initials: M
authors.lastname: Mateos
authors.forename: W
authors.initials: W
authors.lastname: Chen
authors.forename: H
authors.initials: H
authors.lastname: Ludwig
authors.forename: D
authors.initials: D
authors.lastname: Joshua
authors.forename: J
authors.initials: J
authors.lastname: Chim
authors.forename: V
authors.initials: V
authors.lastname: Hungria
authors.forename: I
authors.initials: I
authors.lastname: Turesson
authors.forename: B G M
authors.initials: BG
authors.lastname: Durie
authors.forename: S
authors.initials: S
authors.lastname: Lonial
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000628:therapy*; D014182:Transplantation, Autologous
chemical_list: D000970:Antineoplastic Agents